Dark
Light
System
Institutional Investment Manager
Alyeska Investment Group, L.P.
Alyeska Investment Group, L.P. (CIK: 0001453072) incorporated in Delaware, located at 77 West Wacker Drive, Chicago, IL. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 457 holdings with a total value of $8,519,841,000.
#
Name
Shares
Value ($)
%
Options
Notes
401 Teladoc, Inc. 37,355 833,000 0.01%
402 VTV THERAPEUTICS INC 126,951 828,000 0.01%
403 AGROFRESH SOLUTIONS COM 103,470 822,000 0.01%
404 Natera, Inc. 75,000 814,000 0.01%
405 SERES THERAPEUTICS INC 25,954 769,000 0.01%
406 PARNELL PHARMACEUTICALS HOLDINGS LTD 221,894 763,000 0.01%
407 DISCOVERY LABORATORIES INC N 2,500,000 750,000 0.01% Call
408 ARGOS THERAPEUTICS INC 144,025 694,000 0.01%
409 BELLEROPHON THERAPEUTICS INC 131,472 682,000 0.01%
410 VALEANT PHARMACEUTICALS INTL 3,652 651,000 0.01%
411 PTC THERAPEUTICS INC 24,158 645,000 0.01%
412 Nivalis Therapeutics Inc 49,008 636,000 0.01%
413 City Office Reit, Inc. 55,747 633,000 0.01%
414 DAVIDSTEA INC 40,000 626,000 0.01%
415 SYNTHETIC BIOLOGICS INCORPORATED 275,188 625,000 0.01%
416 MEDGENICS INC 78,575 614,000 0.01%
417 BIOAMBER INC 113,826 609,000 0.01% Call
418 ALARM COM HLDGS INC 51,736 603,000 0.01%
419 HOME LN SERVICING SOLUTIONS LT ORD SHS 864,801 601,000 0.01%
420 LOMBARD MEDICAL INC 167,004 596,000 0.01%
421 CARA THERAPEUTICS INC 41,278 590,000 0.01%
422 NANTKWEST INC COM 50,000 573,000 0.01%
423 VWR CORP 20,900 537,000 0.01%
424 BIND THERAPEUTICS INC 114,786 512,000 0.01% Call
425 VITAE PHARMACEUTICALS INC 45,631 502,000 0.01%
426 ADR - Nabriva Therapeutics AG- Usd 52,563 499,000 0.01%
427 TRANSITION THERAPEUTICS INC 271,764 486,000 0.01%
428 ADMA BIOLOGICS, INC. 55,943 468,000 0.01%
429 TCP INTL HLDGS LTD 153,287 422,000 0.00%
430 MARRONE BIO INNOVATIONS INC 197,881 418,000 0.00%
431 OASIS PETE INC NEW 48,031 417,000 0.00%
432 WALKER & DUNLOP INC COM 15,347 400,000 0.00%
433 Carbylan Therapeutics Inc. 109,241 390,000 0.00%
434 IDENTIV INC 106,085 370,000 0.00%
435 Egalet Corp 27,518 363,000 0.00%
436 Abraxas Petroleum Corp 279,717 358,000 0.00%
437 CYTOKINETICS INC 50,607 339,000 0.00% Call
438 Catabasis Pharmaceuticals Inc 40,220 325,000 0.00%
439 ROKA BIOSCIENCE INC 165,991 324,000 0.00%
440 BIOAMBER INC 56,706 303,000 0.00%
441 TRILLIUM THERAPEUTICS INC 22,378 292,000 0.00%
442 CYTOKINETICS INC 40,485 271,000 0.00%
443 APIGEE CORP 24,544 259,000 0.00%
444 CEMPRA INC 9,201 256,000 0.00%
445 ORION ENGINEERED CARBONS S A 16,700 241,000 0.00%
446 QUOTIENT LTD 17,994 234,000 0.00%
447 LINCOLN EDL SVCS CORP 442,633 226,000 0.00%
448 XENCOR INC COM 16,317 200,000 0.00%
449 GLYCOMIMETICS INC 35,036 196,000 0.00%
450 INVUITY INC 13,268 186,000 0.00%
Page 9 of 10

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-15-000164, filed 2015.11.16), New Holdings filing (0001164691-16-000297, filed 2016.08.17), New Holdings filing (0001164691-16-000272, filed 2016.05.19). and New Holdings filing (0001164691-16-000243, filed 2016.02.18).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.